Status:
COMPLETED
Retrospective Study for Diagnosis of Undetected IgG4 Related Diseases in Patients With High Serum IgG4 Levels.
Lead Sponsor:
Meir Medical Center
Conditions:
Undiagnosed IgG4 Related Diseases
Eligibility:
All Genders
Brief Summary
Immunoglobulin G4-related disease (IgG4-RD) is an increasingly recognized syndrome of unknown etiology comprised of a collection of disorders that share specific pathologic, serologic, and clinical fe...
Detailed Description
IgG4 is a unique antibody in both structure and function. This molecule accounts for less than 5% of the total IgG in healthy persons and is the least abundant IgG subclass. In contrast to IgG1, IgG2,...
Eligibility Criteria
Inclusion
- All patients that where admitted during the period of January 2000 to June 2014 at MEIR HOSPITAL KFAR SAVA, with at least one result of a high serum level of IGG4 according to the accepted normal range in our laboratory (more than 100mg/dL) and to whom biopsy of a suitable tissue was obtained for other reasons than IGG4 Related Diseases.
- Both genders will be included.
- Patients of all ages.
Exclusion
- Patients who have already been diagnosed with IGG4-Related Diseases.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT02229448
Start Date
October 1 2014
End Date
September 1 2015
Last Update
November 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel, 44281